Tenet Healthcare Corp (THC) concluded trading on Wednesday at a closing price of $126.19, with 4.55 million shares of worth about $574.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.70% during that period and on February 12, 2025 the price saw a loss of about -9.10%. Currently the company’s common shares owned by public are about 95.10M shares, out of which, 92.72M shares are available for trading.
Stock saw a price change of -12.96% in past 5 days and over the past one month there was a price change of -2.38%. Year-to-date (YTD), THC shares are showing a performance of -0.03% which increased to 43.25% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $86.90 but also hit the highest price of $171.20 during that period. The average intraday trading volume for Tenet Healthcare Corp shares is 1.25 million. The stock is currently trading -8.44% below its 20-day simple moving average (SMA20), while that difference is down -6.21% for SMA50 and it goes to -11.96% lower than SMA200.
Tenet Healthcare Corp (NYSE: THC) currently have 95.10M outstanding shares and institutions hold larger chunk of about 98.89% of that.
The stock has a current market capitalization of $12.00B and its 3Y-monthly beta is at 2.05. PE ratio of stock for trailing 12 months is 3.91, while it has posted earnings per share of $32.24 in the same period. Its PEG reads 0.61 and has Quick Ratio of 1.70 while making debt-to-equity ratio of 3.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for THC, volatility over the week remained 6.21% while standing at 3.88% over the month.
Stock’s fiscal year EPS is expected to drop by -5.40% while it is estimated to increase by 13.38% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on December 17, 2024 offering an Overweight rating for the stock and assigned a target price of $175 to it. Coverage by Goldman stated Tenet Healthcare Corp (THC) stock as a Neutral in their note to investors on December 16, 2024, suggesting a price target of $140 for the stock. On November 25, 2024, Wells Fargo Downgrade their recommendations, while on November 22, 2024, Raymond James Downgrade their ratings for the stock with a price target of $195. Stock get an Overweight rating from KeyBanc Capital Markets on October 11, 2024.
